Helene Z.
- Country
- France
- Department
- Department of Neurology
Research Overview
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Randomized open-label trial comparing 2-month versus 6-month schedules of adjuvanted recombinant VZV glycoprotein E vaccine in MS and NMOSD patients on anti‑CD20 therapy
- A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED NATIONAL MULTICENTER PHASE 3 TRIAL TO EVALUATE THE EFFICACY OF AZATHIOPRINE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY ASSOCIATED DISEASE (MOG-AD) AFTER A FIRST ATTACK : MOGWAI
Data & Insights
Has run more than one trial at 31 of 197 partner sites.
Specializations
Multiple Sclerosis Management
The investigator specializes in innovative treatment approaches for Multiple Sclerosis, with particular emphasis on therapy optimization in specific patient populations.
- Age-specific treatment strategies
- Disease-modifying therapy management
- Treatment discontinuation protocols
Primary focus includes evaluating treatment strategies for patients over 55 years with stable relapsing-remitting multiple sclerosis.
Neurological Disorders
Expertise extends to various neurological conditions, particularly Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOG-AD) and its treatment modalities.
- Autoimmune neurological conditions
- Relapse prevention strategies
- Novel therapeutic approaches
Active involvement in developing preventive treatments for patients with first-attack MOG-AD.
Treatment De-escalation Studies
Leading research in therapeutic de-escalation strategies, particularly focusing on anti-CD20 therapy transitions and platform therapies in MS patients.
- Maintenance therapy optimization
- Long-term treatment outcomes
- Patient-specific treatment protocols
Specialized interest in comparing maintenance versus de-escalation approaches in relapsing-remitting MS treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.